InnoCan Pharma Corporation to announced its been engaged into a manufacturing and distribution agreement dated August, 2021 with Ayurcann Inc. a major Health Canada licensed producer and distributor of CBD products. Pursuant to the terms of the Manufacturing and Distribution Agreement, Innocan has engaged Ayurcann to manufacture Innocan's CBD Topicals consisting of its Relief and Go and SHIRTM collection, at Ayurcann's licensed facility and to act as the exclusive Canadian distributor for these products. Under the Manufacturing and Distribution Agreement, Ayurcann shall pay Innocan Pharma royalties based on net sales of the products by Ayurcann.

The Manufacturing and Distribution Agreement is subject to Health Canada approval which is expected within the next few months.